#### Cancers Staged Using This Staging System  
All malignancies arising in the major salivary glands are staged by the rules outlined in this chapter.  

#### Cancers Not Staged Using This Staging System  
<table>
<tr>
<th>These histopathologic types of cancer ...</th>
<th>Are staged according to the classification for ...</th>
<th>And can be found in chapter ...</th>
</tr>
<tr>
<td>Lymphoma</td>
<td>Hodgkin and Non-Hodgkin Lymphoma</td>
<td>79</td>
</tr>
<tr>
<td>Minor salivary gland tumors</td>
<td>The primary site in which they arise, staged similar to squamous cell carcinoma</td>
<td>N/A</td>
</tr>
</table>

#### Summary of Changes  
<table>
<tr>
<th>Change</th>
<th>Details of Change</th>
<th>Level of Evidence</th>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Separate N staging approaches have been described for human papilloma virus (HPV)-related and HPV-unrelated cancers.</td>
<td>II1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>Separate N category approaches have been described for patients treated without cervical lymph node dissection (clinical N) and patients treated with cervical lymph neck dissection (pathological N).</td>
<td>II1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>Extranodal extension (ENE) is introduced as a descriptor in all HPV- unrelated cancers.</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>ENE in HPV negative cancers: Only clinically and radiographically overt ENE should be used for cN.</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>ENE in HPV negative cancers: Any pathologically detected ENE is considered ENE(+) and is used for pN.</td>
<td>II2</td>
</tr>
</table>

To access the AJCC cancer staging forms, please visit www.cancerstaging.org.  
<!-- PageFooter="American College of Surgeons 2017 M.B. Amin et al. (eds.), AJCC Cancer Staging Manual, Eighth Edition, DOI 10.1007/978-3-319-40618-3_8" -->
<!-- PageNumber="95" -->
<!-- PageBreak -->  
